Today, the Honourable Mark Holland, Canada’s Minister of Health, and the Honourable Sylvia Jones, Ontario’s Minister of Health, announced a bilateral agreement investing over $535 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.